Astera Labs, Inc. ALAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 115.24% | 98.48% | 104.18% | 115.13% | 136.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 115.24% | 98.48% | 104.18% | 115.13% | 136.51% |
| Cost of Revenue | 128.51% | 101.64% | 102.26% | 121.46% | 159.83% |
| Gross Profit | 110.91% | 97.46% | 104.79% | 113.17% | 129.79% |
| SG&A Expenses | 31.80% | 10.63% | -5.31% | -22.99% | -4.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.04% | 64.84% | 51.76% | 32.54% | 49.29% |
| Operating Income | 272.48% | 546.34% | 1,126.73% | 249.42% | 199.46% |
| Income Before Tax | 198.24% | 278.42% | 1,225.91% | 366.76% | 283.33% |
| Income Tax Expenses | 71.09% | -215.18% | 110.57% | -159.71% | -506.93% |
| Earnings from Continuing Operations | 131.98% | 268.91% | 546.55% | 362.68% | 311.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 131.98% | 268.91% | 546.55% | 362.68% | 311.99% |
| EBIT | 272.48% | 546.34% | 1,126.73% | 249.42% | 199.46% |
| EBITDA | 269.85% | 511.82% | 1,385.94% | 259.64% | 206.79% |
| EPS Basic | 122.25% | 254.96% | 529.30% | 176.73% | 180.41% |
| Normalized Basic EPS | 186.55% | 264.43% | 1,211.66% | 184.60% | 168.00% |
| EPS Diluted | 126.90% | 263.08% | 583.70% | 170.42% | 173.79% |
| Normalized Diluted EPS | 192.16% | 269.47% | 1,333.44% | 178.28% | 162.83% |
| Average Basic Shares Outstanding | 4.69% | 5.38% | 5.98% | 26.91% | 62.68% |
| Average Diluted Shares Outstanding | 2.15% | 5.17% | 7.99% | 32.45% | 77.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |